<DOC>
	<DOCNO>NCT02664116</DOCNO>
	<brief_summary>This research conduct see oral drug Cambia effective relieving severe migraine headache injectable drug ketorolac .</brief_summary>
	<brief_title>IM Ketorolac v Cambia Acute Treatment Severe Migraine</brief_title>
	<detailed_description>The treatment severe migraine often require patient office visit treatment ER urgent care set . This due minimal efficacy PO treatment migraine severe , therefore need parenteral treatment . IM Ketorolac one mainstay parenteral treatment . There unmet need effective at-home treatment regimen severe migraine . Despite FDA approval Cambia acute migraine treatment , insurance reticent cover treatment due high cost comparison generic diclofenac tablet , despite superior efficacy Cambia comparison generic diclofenac tablet ( Diener , Cephalalgia 2006 ) . One objective study would provide rationale justify insurance coverage treatment comparison generic tablet , home treatment less costly office visit emergency department visit receive IM ketorolac . A previous study Cambia demonstrate formulation diclofenac potassium oral solution effective reduce pain intensity within 30 minute , may relate 15-minute Tmax associate formulation . The rapid-onset benefit sustain 24 hour post-treatment ( Lipton , Cephalalgia 2010 )</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Patients meet IHS criterion migraine Age 18 65 At least 2 migraine attack per month Able give write consent Willing complete entire course study Current headache duration great equal 36 hour Pregnant nursing Significant medical psychiatric disease History gastritis , gastric ulcer , GI bleed Renal insufficiency Hepatic insufficiency History opioid dependence within last 10 year currently Any current prior use DICLOFENAC POTASSIUM POWDER FOR ORAL SOLUTION ( CAMBIA ) Past allergic reaction DICLOFENAC NSAIDs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Severe Migraine Headache</keyword>
</DOC>